• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唑硫代乙酰胺:一种极具开发金属β-内酰胺酶抑制剂潜力的骨架结构。

Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.

作者信息

Yang Shao-Kang, Kang Joon S, Oelschlaeger Peter, Yang Ke-Wu

机构信息

Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education, College of Chemistry and Materials Science, Northwest University , Xi'an 710127, P. R. China.

Department of Biological Sciences, California State Polytechnic University , 3801 West Temple Avenue, Pomona, California 91768, United States.

出版信息

ACS Med Chem Lett. 2015 Feb 12;6(4):455-60. doi: 10.1021/ml500534c. eCollection 2015 Apr 9.

DOI:10.1021/ml500534c
PMID:25893049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4394341/
Abstract

A new scaffold, azolylthioacetamide, was constructed and assayed against metallo-β-lactamases (MβLs). The obtained molecules specifically inhibited MβL ImiS, and 1c was found to be the most potent inhibitor, with a K i = 1.2 μM using imipenem as substrate. Structure-activity relationships reveal that the aromatic carboxyl improves inhibitory activity of the inhibitors, but the aliphatic carboxyl does not. Compounds 1c-d and 1h-i showed the best antibacterial activities against E. coli BL21(DE3) cells producing CcrA or ImiS, resulting in 32- and 8-fold reduction in MIC values, respectively; 1c and 1f-j resulted in a reduction in MIC against P. aeruginosa. Docking studies revealed that 1a, 1c, and 1d fit tightly into the substrate binding site of CphA as a proxy for ImiS with the aromatic carboxylate forming interactions with Lys224, the Zn(II) ion, the backbone of Asn233, and hydrophobic portions of the inhibitors aligning with hydrophobic patches of the protein surface.

摘要

构建了一种新的支架唑基硫代乙酰胺,并对金属β-内酰胺酶(MβLs)进行了检测。所得到的分子特异性抑制MβL ImiS,发现1c是最有效的抑制剂,以亚胺培南为底物时其Ki = 1.2 μM。构效关系表明,芳香族羧基可提高抑制剂的抑制活性,而脂肪族羧基则不然。化合物1c - d和1h - i对产生CcrA或ImiS的大肠杆菌BL21(DE3)细胞显示出最佳抗菌活性,MIC值分别降低32倍和8倍;1c和1f - j使铜绿假单胞菌的MIC降低。对接研究表明,1a、1c和1d紧密契合作为ImiS替代物的CphA的底物结合位点,芳香族羧酸盐与Lys224、Zn(II)离子、Asn233的主链形成相互作用,抑制剂的疏水部分与蛋白质表面的疏水区域对齐。

相似文献

1
Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.唑硫代乙酰胺:一种极具开发金属β-内酰胺酶抑制剂潜力的骨架结构。
ACS Med Chem Lett. 2015 Feb 12;6(4):455-60. doi: 10.1021/ml500534c. eCollection 2015 Apr 9.
2
-Substituted benzenesulfonamide: a potent scaffold for the development of metallo-β-lactamase ImiS inhibitors.-取代苯磺酰胺:一种用于开发金属β-内酰胺酶ImiS抑制剂的有效骨架。
RSC Med Chem. 2020 Jan 10;11(2):259-267. doi: 10.1039/c9md00455f. eCollection 2020 Feb 1.
3
Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.二羟基苯基取代的硫代半卡巴腙:一种用于开发金属β-内酰胺酶抑制剂和抗菌剂的有效骨架。
Bioorg Chem. 2022 Oct;127:105928. doi: 10.1016/j.bioorg.2022.105928. Epub 2022 Jun 13.
4
Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors.若丹宁作为开发广谱金属β-内酰胺酶抑制剂的有效骨架。
ACS Med Chem Lett. 2018 Mar 22;9(4):359-364. doi: 10.1021/acsmedchemlett.7b00548. eCollection 2018 Apr 12.
5
Amino Acid Thioester Derivatives: A Highly Promising Scaffold for the Development of Metallo-β-lactamase L1 Inhibitors.氨基酸硫酯衍生物:一种用于开发金属β-内酰胺酶L1抑制剂的极具潜力的骨架。
ACS Med Chem Lett. 2015 Apr 23;6(6):660-4. doi: 10.1021/acsmedchemlett.5b00098. eCollection 2015 Jun 11.
6
N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria.N-杂环二羧酸:广谱金属β-内酰胺酶抑制剂,具有针对抗药性细菌的协同抗菌作用。
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5185-9. doi: 10.1016/j.bmcl.2012.06.074. Epub 2012 Jul 1.
7
Amino Acid Thioesters Exhibit Inhibitory Activity against B1-B3 Subclasses of Metallo-β-lactamases.氨基酸硫酯对金属β-内酰胺酶的B1-B3亚类具有抑制活性。
Chem Pharm Bull (Tokyo). 2019;67(2):135-142. doi: 10.1248/cpb.c18-00717.
8
Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors.卤代三唑硫代乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Molecules. 2019 Mar 25;24(6):1174. doi: 10.3390/molecules24061174.
9
Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.唑硫基乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5225-5229. doi: 10.1016/j.bmcl.2017.10.038. Epub 2017 Oct 20.
10
Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.发现羟肟酸是一种有前景的支架,能够双重抑制金属酶和丝氨酸β-内酰胺酶。
Eur J Med Chem. 2024 Feb 5;265:116055. doi: 10.1016/j.ejmech.2023.116055. Epub 2023 Dec 16.

引用本文的文献

1
In Silico Evaluation of Potential NDM-1 Inhibitors: An Integrated Docking and Molecular Dynamics Approach.潜在NDM-1抑制剂的计算机模拟评估:一种结合对接和分子动力学的方法。
Pharmaceuticals (Basel). 2024 Dec 19;17(12):1715. doi: 10.3390/ph17121715.
2
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study.苯并噻唑类 1,3,4-噻二唑作为抗增殖杂合体的鉴定,靶向 VEGFR-2 和 BRAF 激酶:设计、合成、生物评价和计算机模拟研究。
Molecules. 2024 Jul 4;29(13):3186. doi: 10.3390/molecules29133186.
3
Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases.阐明金属β-内酰胺酶抑制剂的关键化学部分,并确定目标金属β-内酰胺酶的优先级。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2318830. doi: 10.1080/14756366.2024.2318830. Epub 2024 Mar 15.
4
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and study.新型苯并噻唑类杂合体作为潜在的 VEGFR-2 抑制剂:设计、合成、抗癌评价及研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2166036. doi: 10.1080/14756366.2023.2166036.
5
A Modified Vancomycin Molecule Confers Potent Inhibitory Efficacy against Resistant Bacteria Mediated by Metallo-β-Lactamases.一种改良的万古霉素分子通过金属β-内酰胺酶对耐药细菌具有强大的抑制作用。
Molecules. 2022 Nov 9;27(22):7685. doi: 10.3390/molecules27227685.
6
-Substituted benzenesulfonamide: a potent scaffold for the development of metallo-β-lactamase ImiS inhibitors.-取代苯磺酰胺:一种用于开发金属β-内酰胺酶ImiS抑制剂的有效骨架。
RSC Med Chem. 2020 Jan 10;11(2):259-267. doi: 10.1039/c9md00455f. eCollection 2020 Feb 1.
7
Binding of 2-(Triazolylthio)acetamides to Metallo-β-lactamase CcrA Determined with NMR.利用核磁共振确定2-(三唑基硫代)乙酰胺与金属β-内酰胺酶CcrA的结合情况。
ACS Omega. 2020 Aug 18;5(34):21570-21578. doi: 10.1021/acsomega.0c02187. eCollection 2020 Sep 1.
8
Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors.基于靛红衍生物的高效合成、生物评价及对接研究及其作为胱天蛋白酶抑制剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1674-1684. doi: 10.1080/14756366.2020.1809388.
9
Synthesis of New Planar-Chiral Linked [2.2]Paracyclophanes--([2.2]-Paracyclophanylcarbamoyl)-4-([2.2]Paracyclophanylcarboxamide, [2.2]Paracyclophanyl-Substituted Triazolthiones and -Substituted Oxadiazoles.新型平面手性联[2.2]对环芳烷的合成--([2.2]-对环芳基碳酰胺基)-4-([2.2]对环芳基甲酰胺基)、[2.2]对环芳基取代三唑硫酮和-取代恶二唑。
Molecules. 2020 Jul 22;25(15):3315. doi: 10.3390/molecules25153315.
10
Discovery and characterization of New Delhi metallo-β-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.发现并鉴定新型德里金属β-内酰胺酶-1 抑制剂肽,增强美罗培南依赖型杀菌作用,对产碳青霉烯酶肠杆菌科细菌。
J Antimicrob Chemother. 2020 Oct 1;75(10):2843-2851. doi: 10.1093/jac/dkaa242.

本文引用的文献

1
Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1).二芳基取代的唑基硫代乙酰胺:新型德里金属β-内酰胺酶-1(NDM-1)抑制剂的发现
ChemMedChem. 2014 Nov;9(11):2445-8. doi: 10.1002/cmdc.201402249. Epub 2014 Jul 22.
2
Recent advances in the discovery of metallo-β-lactamase inhibitors for β-lactam antibiotic-resistant reversing agents.用于逆转β-内酰胺抗生素耐药性的金属β-内酰胺酶抑制剂的最新发现进展。
Curr Drug Targets. 2014;15(7):689-702. doi: 10.2174/1389450115666140326094504.
3
New β-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-β-lactamases.新型β-内酰胺作为碳青霉烯过渡态类似物:金属β-内酰胺酶广谱抑制剂的合成。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5855-9. doi: 10.1016/j.bmcl.2013.08.098. Epub 2013 Sep 8.
4
The ABCD's of β-lactamase nomenclature.β-内酰胺酶命名法的 ABCD。
J Infect Chemother. 2013 Aug;19(4):549-59. doi: 10.1007/s10156-013-0640-7. Epub 2013 Jul 5.
5
N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria.N-杂环二羧酸:广谱金属β-内酰胺酶抑制剂,具有针对抗药性细菌的协同抗菌作用。
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5185-9. doi: 10.1016/j.bmcl.2012.06.074. Epub 2012 Jul 1.
6
Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents.苯并噻唑基)乙酰胺类衍生物的合成及其作为抗菌、抗真菌和抗结核药物的研究。
Eur J Med Chem. 2012 Jul;53:41-51. doi: 10.1016/j.ejmech.2012.03.033. Epub 2012 Mar 28.
7
Mechanistic and spectroscopic studies of metallo-β-lactamase NDM-1.金属β-内酰胺酶 NDM-1 的机制和光谱研究。
Biochemistry. 2012 May 8;51(18):3839-47. doi: 10.1021/bi300056y. Epub 2012 Apr 25.
8
3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors.3-巯基-1,2,4-三唑和 N-酰化硫代卡巴肼作为金属β-内酰胺酶抑制剂。
Bioorg Med Chem Lett. 2012 Jan 1;22(1):380-6. doi: 10.1016/j.bmcl.2011.10.116. Epub 2011 Nov 6.
9
Carbapenems: past, present, and future.碳青霉烯类抗生素:过去、现在和未来。
Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60. doi: 10.1128/AAC.00296-11. Epub 2011 Aug 22.
10
Crystal structure of Serratia fonticola Sfh-I: activation of the nucleophile in mono-zinc metallo-β-lactamases.希瓦氏菌属 Sfh-I 晶体结构:单锌金属β-内酰胺酶中亲核试剂的活化。
J Mol Biol. 2011 Sep 2;411(5):951-9. doi: 10.1016/j.jmb.2011.06.043. Epub 2011 Jul 6.